CJC 1295 & Ipamorelin Blend
Description
A synergistic research blend combining CJC-1295 (GHRH analog) and Ipamorelin (GHRP/GHS), engineered to promote multi-pathway growth hormone secretion and cellular signaling in laboratory models.
Available in 10mg–20mg vials, every lot is third-party tested for identity and purity, with certificates of analysis available on request. Vials arrive sealed and sterile, lyophilized for stability, and ship from our U.S. facility in 2–6 days.
For in vitro laboratory research use only. See the Technical Data tab below for the full mechanism and feature summary.
CJC 1295 & Ipamorelin Blend from Wolf Research is a high-purity research-grade compound intended strictly for laboratory research use.
CJC 1295 & Ipamorelin Blend (CJC-1295 (Mod GRF 1-29) + Ipamorelin combination blend) combines multiple well-characterized research compounds in a single vial for convenient laboratory use. Blend formulations support combination studies while reducing preparation steps in research workflows.
Every lot of CJC 1295 & Ipamorelin Blend is third-party tested for identity and purity, with certificates of analysis available on request. Supplied in sealed, sterile vials and shipped fast from our U.S. facility.
The products offered herein are intended exclusively for research purposes and must be utilized solely within in vitro environments (e.g., test tubes or laboratory settings) for the purposes of testing and experimentation. All information provided on this website is strictly for educational purposes and does not constitute legal or professional advice. It is imperative to acknowledge that the introduction of these products into humans or animals, in any capacity, is strictly prohibited by applicable laws and regulations. Violation of these regulations may result in legal repercussions. These products are intended solely for use by qualified, licensed professionals with the expertise to handle them safely and responsibly. Furthermore, it is important to note that these products are not classified as drugs, food, or cosmetics under any legal definitions. Any misbranding, misuse, or mislabeling of these products within these categories is expressly prohibited and may lead to further legal consequences. By adhering to these guidelines, you ensure compliance with all regulatory frameworks and contribute to the responsible conduct of scientific research.
Technical Data
| A synergistic research blend combining CJC-1295 (GHRH analog) and Ipamorelin (GHRP/GHS), engineered to promote multi-pathway growth hormone secretion and cellular signaling in laboratory models. | |
|---|---|
| Key Benefits & Highlights | |
| Dual-Pathway Secretagogue Action | Combines GHRH receptor stimulation (CJC-1295) with selective Ghrelin/GHS receptor activation (Ipamorelin) to elicit enhanced, natural growth hormone pulses. |
| Targeted Pulsatile Release | Designed to trigger robust growth hormone elevation without inducing significant increases in baseline cortisol, prolactin, or aldosterone levels. |
| Metabolic & Tissue Signaling | Researched for its downstream effects on IGF-1 expression, cellular repair mechanisms, lean tissue preservation, and lipolysis acceleration. |
| High Chemical Purity | Synthesized and verified via analytical testing to ensure exact sequence fidelity and minimal experimental variance. |
| Optimized Research Blend | Pre-formulated in standardized ratios to provide high reproducibility and convenience across in vitro endocrinology and metabolic assays. |
| Feature Summary | |
| Product Class | Dual Growth Hormone Secretagogue Blend (GHRH Analog + GHRP/GHS) |
| Active Components | CJC-1295 + Ipamorelin |
| Primary Application | In vitro dual-pathway growth hormone secretion & metabolic signaling research |
| Grade | Laboratory / Research Grade Only |